Anti-mesothelin CAR T Cells for Patients With Recurrent or Metastatic Malignant Tumors
Clinical trial NCT02930993 · UNKNOWN
Trial details
- NCT number
- NCT02930993
- Sponsor
- China Meitan General Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2018-08-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.